|Articles|May 3, 2003
Several studies to provide new information, data about olopatadine
Four studies about olopatadine hydrochloride ophthalmic solution 0.1%(Patanol, Alcon Laboratories) and olopatadine hydrochloride ophthalmic solution0.2% (Patanol once-a-day) will be presented at ARVO, Alcon Laboratoriesannounced.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement